Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.

CONCLUSION: Belimumab is effective and safe when used in clinical practice setting. PMID: 28935492 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28935492?dopt=Abstract

Source: Journal of Autoimmunity - September 18, 2017 Category: Allergy & Immunology Authors: Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani Tags: J Autoimmun Source Type: research